Patients with severe COVID-19 exhibited expansion of plasmablasts along with elevated levels of SARS-CoV-2 spike receptor binding domain (RBD)–specific IgM and IgG compared with the healthy individuals, indicating an altered B-cell subset with a strong SARS-CoV-2–specific humoral response (33). Here, CD40LG is linked to COVID-19.